| valproic acid (CT-010) / Cerebral Therap |
NCT04153175: Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization |
|
|
| Terminated | 2 | 30 | RoW | ICV delivery of CT-010 via an implantable pump and a cranial port and dual lumen catheter (CIC), Placebo delivery via an implantable pump and a cranial port and dual lumen catheter (CIC) | Cerebral Therapeutics LLC | Refractory Epilepsy | 03/24 | 03/24 | | |
NCT02899611: A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures |
|
|
| Completed | 1/2 | 6 | RoW | Valproate, Valproic acid, Depacon, Epilim | Cerebral Therapeutics LLC, Neuroscience Trials Australia | Epilepsy | 06/21 | 06/21 | | |
NCT04529954: Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion |
|
|
| Terminated | 1/2 | 20 | RoW | Valproic Acid delivered to ICV | Cerebral Therapeutics LLC | Focal Epilepsy | 03/24 | 03/24 | | |
